Canadian Society of Nephrology Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis: Management of Glomerulonephritis in Adults

被引：27

作者：

Cybulsky, Andrey V. ^{[1
]}

Walsh, Michael ^{[2
]}

Knoll, Greg ^{[3
]}

Hladunewich, Michelle ^{[4
]}

Bargman, Joanne ^{[4
]}

Reich, Heather ^{[4
]}

Humar, Atul ^{[5
]}

Samuel, Susan ^{[6
]}

Bitzan, Martin ^{[7
]}

Zappitelli, Michael ^{[7
]}

Dart, Allison ^{[8
]}

Mammen, Cherry ^{[9
]}

Pinsk, Maury ^{[6
]}

Muirhead, Norman ^{[10
]}

机构：

[1] McGill Univ, Dept Med, Montreal, PQ, Canada

[2] McMaster Univ, Dept Med, Div Nephrol, Hamilton, ON, Canada

[3] Univ Ottawa, Dept Med, Div Nephrol, Ottawa, ON, Canada

[4] Univ Toronto, Dept Med, Toronto, ON, Canada

[5] Univ Alberta, Edmonton, AB, Canada

[6] Univ Alberta, Dept Pediat, Edmonton, AB, Canada

[7] Montreal Childrens Hosp, Montreal, PQ H3H 1P3, Canada

[8] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada

[9] Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada

[10] Univ Western Ontario, Dept Med, Div Nephrol, London, ON N6A 5A5, Canada

来源：

AMERICAN JOURNAL OF KIDNEY DISEASES | 2014年 / 63卷 / 03期

关键词：

Clinical practice guideline implementation; KDIGO (Kidney Disease: Improving Global Outcomes); Canadian Society of Nephrology (CSN); nephrotic syndrome; glomerulonephritis; ANTIBODY-ASSOCIATED VASCULITIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TERM-FOLLOW-UP; IDIOPATHIC MEMBRANOUS NEPHROPATHY; CHRONIC KIDNEY-DISEASE; DENSE DEPOSIT DISEASE; IGA NEPHROPATHY; LONG-TERM; MYCOPHENOLATE-MOFETIL; OXFORD CLASSIFICATION;

D O I：

10.1053/j.ajkd.2013.12.001

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

The KDIGO (Kidney Disease: Improving Global Outcomes) clinical practice guideline for management of glomerulonephritis was recently released. The Canadian Society of Nephrology convened a working group to review the recommendations and comment on their relevancy and applicability to the Canadian context. A subgroup of adult nephrologists reviewed the guideline statements for management of glomerular disease in adults and agreed with most of the guideline statements developed by KDIGO. This commentary highlights areas for which there is lack of evidence and areas in need of translation of evidence into clinical practice. Areas of controversy or uncertainty, including the choice of second-line agents, are discussed in more detail. Existing practice variation also is addressed. The relevance of treatment recommendations to the Canadian practitioner is discussed. (C) 2014 by the National Kidney Foundation, Inc.

引用

页码：363 / 377

页数：15

共 50 条

[31] KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Blood Pressure in CKD
Drawz, Paul E.
Beddhu, Srinivasan
Bignall, O. N. Ray, II
Cohen, Jordana B.
Flynn, Joseph T.
Ku, Elaine
Rahman, Mahboob
Thomas, George
Weir, Matthew R.
Whelton, Paul K.
AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (03) : 311 - 327
[32] Comments on 'KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease' Reply
Levin, Adeera
Stevens, Paul E.
KIDNEY INTERNATIONAL, 2013, 84 (03) : 623 - 623
[33] The need for improved uptake of the KDIGO glomerulonephritis guidelines into clinical practice in Canada: a survey of nephrologists
Barbour, Sean
Beaulieu, Monica
Gill, Jagbir
Espino-Hernandez, Gabriela
Reich, Heather N.
Levin, Adeera
CLINICAL KIDNEY JOURNAL, 2014, 7 (06) : 538 - 545
[34] KDIGO 2024 CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF LUPUS NEPHRITIS
Grams, Morgan E.
Jadoul, Michel
KIDNEY INTERNATIONAL, 2024, 105 (01) : S1 - S69
[35] KHA-CARI commentary on the KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease
Palmer, Suetonia C.
Strippoli, Giovanni F. M.
Craig, Jonathan C.
NEPHROLOGY, 2014, 19 (11) : 663 - 666
[36] KDOQI US Commentary on the 2020 KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation
Puttarajappa, Chethan M.
Schinstock, Carrie A.
Wu, Christine M.
Leca, Nicolae
Kumar, Vineeta
Vasudev, Brahm S.
Hariharan, Sundaram
AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 77 (06) : 833 - 856
[37] KDIGO 2021 CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF GLOMERULAR DISEASES
Rovin, Brad H.
Adler, Sharon G.
Barratt, Jonathan
Bridoux, Frank
Burdge, Kelly A.
Chan, Tak Mao
Cook, H. Terence
Fervenza, Fernando C.
Gibson, Keisha L.
Glassock, Richard J.
Jayne, David R. W.
Jha, Vivekanand
Liew, Adrian
Liu, Zhi-Hong
Mejia-Vilet, Juan M.
Nester, Carla M.
Radhakrishnan, Jai
Rave, Elizabeth M.
Reich, Heather N.
Ronco, Pierre
Sanders, Jan-Stephan F.
Sethi, Sanjeev
Suzuki, Yusuke
Tang, Sydney C. W.
Tesar, Vladimir
Vivarelli, Marina
Wetzels, Jack F. M.
Lytvyn, Lyubov
Craig, Jonathan C.
Tunnicliffe, David J.
Howell, Martin
Tonelli, Marcello A.
Cheung, Michael
Earley, Amy
Floege, Juergen
KIDNEY INTERNATIONAL, 2021, 100 (04) : S1 - S276
[38] Commentary on the endocrine society clinical practice guideline on the "treatment of hypercalcemia of malignancy in adults"
Fuleihan, Ghada El-Hajj
Drake, Matthew T.
METABOLISM-CLINICAL AND EXPERIMENTAL, 2023, 143
[39] Commentary on the 2021 update of the KDIGO clinical practice guideline for management of blood pressure in chronic kidney disease
See, Emily J.
Cullen, Vanessa
NEPHROLOGY, 2025, 30 (01)
[40] KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease in Children and Adults: a commentary from the European Renal Best Practice (ERBP)
Iatridi, Fotini
Carrero, Juan Jesus
Gall, Emilie Cornec-Le
Kanbay, Mehmet
Luyckx, Valerie
Shroff, Rukshana
Ferro, Charles J.
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 40 (02) : 273 - 282

← 1 2 3 4 5 →